IGF-1 LR3 is a modified analog of insulin-like growth factor 1 (IGF-1) studied in laboratory research involving growth-factor signaling, receptor interactions, cell signaling, and peptide structure-function relationships. The name Long Arginine 3 IGF-1 refers to structural modifications that distinguish IGF-1 LR3 from native IGF-1. Helix Bio provides IGF-1 LR3 as a research-use-only material for qualified laboratory and non-clinical research. It is not intended for human consumption or self-administration.
HPLC certified
Independent analysis
Highest standard
Full traceability
IGF-1 LR3, also known as Long R3 IGF-1 or Long Arginine 3 IGF-1, is a modified form of IGF-1 used as a research tool in studies of growth-factor biology.
Native IGF-1 is a peptide growth factor involved in complex cellular signaling. IGF-1 LR3 has structural modifications designed to alter characteristics such as interactions with IGF-binding proteins, making it useful for researchers studying differences between native IGF-1 and modified IGF-1 analogs.
Primary research areas include:
IGF-1 LR3 is structurally related to native IGF-1 but is not identical to the native molecule. The "LR3" designation refers to the Long Arginine 3 modification. Structural differences between IGF-1 LR3 and native IGF-1 are important in research because molecular structure can influence ligand interactions, binding characteristics, and experimental behavior. For this reason, IGF-1 LR3 should be treated as a distinct research compound rather than simply another name for native IGF-1.
IGF-1 LR3 is relevant to research involving IGF-1 receptor (IGF1R) signaling and cellular signaling pathways. Researchers may investigate how modified IGF-1 analogs interact with IGF-related receptors, how structural modifications influence receptor signaling, differences between native IGF-1 and modified analogs, cellular responses to growth-factor signaling, and relationships between peptide structure and biological activity.
One important research distinction between IGF-1 LR3 and native IGF-1 involves binding-protein interactions. IGF-1 normally exists within a complex biological environment that includes IGF-binding proteins. Modified analogs such as IGF-1 LR3 are studied partly because structural changes can affect these interactions, giving researchers an opportunity to investigate how changes in binding-protein affinity may influence experimental models of IGF-related signaling. This should be interpreted as a laboratory research characteristic, not as a claim about predictable effects in humans.
| Research Characteristic | IGF-1 LR3 | Native IGF-1 |
|---|---|---|
| Molecular relationship | Modified IGF-1 analog | Naturally occurring IGF-1 |
| Structural profile | Contains modifications relative to native IGF-1 | Native molecular structure |
| Binding-protein research | Studied for altered binding characteristics | Naturally interacts with IGF-binding proteins |
| Research focus | Analog structure, signaling and receptor studies | Native IGF-1 biology and signaling |
| Research purpose | Comparative and mechanistic laboratory studies | Studies of native IGF-1 biology |
The key point is that IGF-1 LR3 is not the same molecule as native IGF-1.
IGF-1 LR3 and MGF are both relevant to research involving growth-factor signaling, but they are distinct research peptides with different structures and research contexts. Researchers comparing the two should focus on molecular structure, receptor interactions, signaling pathways, experimental model, research objective, and analytical characterization.
IGF-1 LR3 provides researchers with a defined IGF-1 analog for studying how structural modifications can influence growth-factor-related research systems. It can be particularly relevant when an experimental project requires comparison between a modified IGF-1 analog and native IGF-1 or other growth-factor peptides.
When evaluating an IGF-1 LR3 research supplier, researchers should look beyond a product name or advertised purity percentage. Important quality considerations include clear compound identification, batch-specific analytical documentation, appropriate purity testing, HPLC results where applicable, mass spectrometry characterization where applicable, Certificate of Analysis documentation, transparent sourcing information, and clearly stated research-use-only status. Specific Helix Bio testing claims are published only when supported by current batch documentation.
IGF-1 LR3 is not intended for human consumption, self-administration, diagnosis, treatment, or prevention of disease.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Cyclic peptides resist protease degradation and reach undruggable targets. Learn how peptide cyclization works and why stability improves. Explore the research.
How continuous flow, automation, enzymatic routes and AI are changing peptide synthesis technology, and what it means for research peptide purity and supply.
AI now designs peptides from scratch. How AlphaFold 3, RFdiffusion and protein language models reshaped peptide discovery in 2026 — research use only.
